Presenilins and Alzheimer’s Disease

1. Front Matter

   Pages I-XV

   PDF

2. Molecular Genetics of the Presenilins in Alzheimer’s Disease

   • P. E. Fraser, G. Yu, G. Levesque, M. Ikeda, M. Nishimura, E. Rogaeva et al.

   Pages 1-10

3. Alzheimer’s Disease: A Matter of Dominance

   • J. Hardy, M. Hutton

   Pages 11-18

4. Alternative Endoproteolysis of the Presenilins and Familial Alzheimer’s Disease

   • R. E. Tanzi, T.-W. Kim, D. M. Kovacs, W. Wasco, R. D. Moir, W. Pettingell et al.

   Pages 19-25

5. The APP and PS1/2 Mutations Linked to Early Onset Familial Alzheimer’s Disease Increase the Extracellular Concentration of Aβ1–42(43)

   • S. G. Younkin

   Pages 27-33

6. Metabolism and Function of Presenilin 1

   • S. S. Sisodia, G. Thinakaran, P. C. Wong, D. R. Borchelt, M. K. Lee, A. Doan et al.

   Pages 35-47

7. Mechanistic Studies of the Effect of Presenilins 1 and 2 on APP Metabolism

   • D. J. Selkoe, W. Xia, J. Zhang, M. B. Podlisny, C. A. Lemere, M. Citron et al.

   Pages 49-58

8. Presenilin 2 — APP Interactions

   • W. Wasco, R. E. Tanzi, R. D. Moir, A. C. Crowley, D. E. Merriam, D. M. Romano et al.

   Pages 59-70

9. The Cellular Biology of Presenilin Proteins and a Novel Mechanism of Amyloid β-Peptide Generation

   • C. Haass, J. Walter, A. Capell, C. Wild-Bode, J. Grünberg, T. Yamazaki et al.

   Pages 71-78

10. Regulation of Presenilin 1 Phosphorylation and Transcriptional Activation of Signal Transduction-Induced Genes by Muscarinic Receptors

    • U. Langer, C. Albrecht, M. Mayhaus, J. Velden, H. Wiegmann, J. Klaudiny et al.

    Pages 79-84

11. Neuronal Regulation of Presenilin-1 Processing

    • H. Hartmann, J. Busciglio, B. A. Yankner

    Pages 85-91

12. Transgenic Approaches to the Study of Alzheimer’s Disease

    • K. Duff

    Pages 93-97

13. Back Matter

    Pages 99-100

    PDF

The discovery in 1995 that defects in the novel presenilin genes harbor defects which cause up to half of all cases of early onset familial Alzheimer's disease cases has rapidly led to the creation of a new and exciting sub-field in Alzheimer's disease research. This has clearly been evidenced by the fact that over 250 papers have now been published regarding the presenilins since their identification in 1995. One of the earliest findings regarding the role of the presenilins in Alzheimer's disease was the discovery that like familial Alzheimer's disease mutations in the amyloid ß protein precursor gene, those in the presenilins lead to dramatically increased production of ß-amyloid in the brains of AD patients. Additionally, the presenilins appear to play roles in programmed cell death (apoptosis) and in CNS development. The provocative chapters in this book written by some of the most highly respected experts in the area of Alzheimer's disease research present some of the latest information concerning the biological function of the presenilins and how defects in these genes cause Alzheimer's disease. The knowledge contained in this volume should help to accelerate ongoing attempts to develop novel treatments for Alzheimer's disease and related disorders.

• Alzheimer's disease
• Alzheimer´s disease
• activation
• biology
• brain
• cell
• cell death
• dementia
• genetics
• metabolism
• molecular genetics
• mutation
• programmed cell death
• regulation
• transcription

• Mayo Clinic Jacksonville, Jacksonville, USA

  S. G. Younkin

• Genetics and Aging Unit and the Department of Neurology, Massachusetts General Hospital-East Harvard Medical School, Boston, USA

  R. E. Tanzi

• Fondation IPSEN, Paris Cedex 16, France

  Y. Christen

Policies and ethics